Vol 10, No 5 (October 2019): Journal of Gastrointestinal Oncology

Original Article

Genomic profiling of cell-free circulating tumor DNA in patients with colorectal cancer and its fidelity to the genomics of the tumor biopsy
Gerald Li, Dean Pavlick, Jon H. Chung, Todd Bauer, Bradford A. Tan, Julio Peguero, Patrick Ward, Andre Kallab, Jose Bufill, Anthony Hoffman, Ahad Sadiq, Jeff Edenfield, Jie He, Matthew Cooke, Jason Hughes, Brady Forcier, Michelle Nahas, Phil Stephens, Siraj M. Ali, Alexa B. Schrock, Jeffrey S. Ross, Vincent A. Miller, Jeffrey P. Gregg
Treatment delays during FOLFOX chemotherapy in patients with colorectal cancer: a multicenter retrospective analysis
Lawrence G. Kogan, S. Lindsey Davis, Gabriel A. Brooks
Identification of potential biomarkers and pathways in ulcerative colitis with combined public mRNA and miRNA expression microarray data analysis
Lili Yang, Yaoyao Bian, Zhengjun Li, Yan Yan, Junyi Li, Wenlin Li, Li Zeng
Loss of ferrochelatase is protective against colon cancer cells: ferrochelatase a possible regulator of the long noncoding RNA H19
Rémi Safi, Tala Mohsen-Kanson, Georges Nemer, Batoul Dekmak, Nelly Rubeiz, Marwan El-Sabban, Dany Nassar, Assaad Eid, Ossama Abbas, Abdul-Ghani Kibbi, Mazen Kurban
Survival trends of metastatic small intestinal neuroendocrine tumor: a population-based analysis of SEER database
Chintan P. Shah, Lazarus K. Mramba, Rohit Bishnoi, Athira Unnikrishnan, Jennifer M. Duff, Sreenivasa R. Chandana
Decreased percentage of neutrophil is a predict factor for the efficacy of trifluridine and tipiracil hydrochloride for pretreated metastatic colorectal cancer
Katsuya Makihara, Rino Fukui, Hitomi Uchiyama, Yasushi Shigeoka, Akihiro Toyokawa
Effect of KRAS mutational status on disease behavior and treatment outcome in patients with metastatic colorectal cancer: intratumor heterogeneity and mutational status
Ayman Rasmy, Alaa Fayed, Ayman Omar, Nermin Fahmy
Rectal cancer in the young: analysis of contributing factors and surgical outcomes
Odinaka Mogor, Agnes Ewongwo, Ogaga Ojameruaye, Viraj Pandit, Pamela Omesiete, Carolina Martinez, Paul Hsu, Aaron Scott, Emad Elquza, Valentine Nfonsam
Accuracy of nodal staging is influenced by sidedness in colon cancer
Ahmed N. Dehal, Daniel Nelson, Shu-Ching Chang, Akram Dahel, Anton J. Bilchik
First line nab-paclitaxel plus gemcitabine in elderly metastatic pancreatic patients: a good choice beyond age
Angelica Petrillo, Annalisa Pappalardo, Filomena Calabrese, Giuseppe Tirino, Luca Pompella, Jole Ventriglia, Maria Maddalena Laterza, Marianna Caterino, Vincenzo Sforza, Vega Iranzo, Maria Biglietto, Michele Orditura, Fortunato Ciardiello, Giovanni Conzo, Carlo Molino, Ferdinando De Vita
Long-term outcomes by response to neoadjuvant chemotherapy or chemoradiation in patients with resected pancreatic adenocarcinoma
Ahmed Khattab, Sunita Patruni, Stephen Abel, Shaakir Hasan, Ethan B. Ludmir, Gene Finley, Dulabh Monga, Rodney E. Wegner, Vivek Verma
Does the addition of adjuvant intraoperative tumor bed chemotherapy during midgut neuroendocrine tumor debulking procedures benefit patients?
Yi-Zarn Wang, Aman Chauhan, Robert A. Ramirez, David T. Beyer, Melissa A. Stevens, Eugene A. Woltering, J. Philip Boudreaux, Lowell Anthony
Clinical outcomes of endoscopic submucosal tunnel dissection compared with conventional endoscopic submucosal dissection for superficial esophageal cancer: a systematic review and meta-analysis
Jia-Xi Lu, De-Liang Liu, Yu-Yong Tan
Phase Ib trial of gemcitabine with yttrium-90 in patients with hepatic metastasis of pancreatobiliary origin
Nariman Nezami, Juan C. Camacho, Nima Kokabi, Bassel F. El-Rayes, Hyun S. Kim
Delivery rate of patients with advanced gastric cancer to third-line chemotherapy and those patients’ characteristics: an analysis in real-world setting
Masayuki Ueno, Akira Doi, Tomohiko Sunami, Hiroshi Takayama, Hirokazu Mouri, Motowo Mizuno
The prognostic value of systemic immune-inflammation index (SII) in patients after radical operation for carcinoma of stomach in gastric cancer
Qingshan Wang, Dayong Zhu
Trends of incidence and survival in patients with gastroenteropancreatic signet ring cell carcinoma: an analysis from the Surveillance, Epidemiology, and End Results program
Hui Li, Zhen Zong, Taicheng Zhou, Lina Sun, Anan Wang, Kunhe Zhang, Chenghao Yi
Quality of life as a fundamental outcome after curative intent gastrectomy for adenocarcinoma: lessons learned from patients
Rodrigo Nascimento Pinheiro, Samantha Mucci, Renato Morato Zanatto, Olavo Magalhães Picanço Junior, Augusto Angelo Granado Bottino, Renata Pereira Fontoura, Gaspar de Jesus Lopes Filho
Proton beam therapy versus stereotactic body radiotherapy for hepatocellular carcinoma: practice patterns, outcomes, and the effect of biologically effective dose escalation
Shaakir Hasan, Stephen Abel, Vivek Verma, Patrick Webster, W. Tristam Arscott, Rodney E. Wegner, Alexander Kirichenko, Charles B. Simone II

Case Report

Successful 5-fluorouracil (5-FU) infusion re-challenge in a metastatic colorectal cancer patient with coronary artery disease who experienced symptoms consistent with coronary vasospasm during first 5-FU infusion
Jason M. Redman, Logan P. Rhea, Alessandra Brofferio, Margaret Whelpley, James L. Gulley, Margaret E. Gatti-Mays, Sheri McMahon, Lisa M. Cordes, Julius Strauss
Asymptomatic esophageal glomus tumor: case report
Cicilia Marcella, Ruihua Shi, Ting Yu, Shakeel Sarwar, Xueqin Wang, Yang Liu
An unusual case of primary acinar cell carcinoma of the liver and its treatment
Sharanpreet Kaur, Devin Morris, Grant Ho, Joline Abrahams, Elber Camacho
A case of gastric small cell carcinoma with metastases to bone and liver
Geethapriya Rajasekaran Rathnakumar, Ashish Gupta, Febin John, Yingxian Liu, Shams Shakil, Elizabeth Guevara